16:28 EST TScan Therapeutics (TCRX) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on TCRX: TScan Therapeutics: Buy Rating Affirmed Amid Promising Growth Prospects and Strong Financial Position TScan Therapeutics reports Q4 EPS (30c), consensus (28c) Tscan Therapeutics, Inc. (TCRX) Q4 Earnings Cheat Sheet
